Target Name: LOC102723409
NCBI ID: G102723409
Review Report on LOC102723409 Target / Biomarker Content of Review Report on LOC102723409 Target / Biomarker
LOC102723409
Other Name(s): uncharacterized LOC102723409 | LOC102723409 variant X5 | Uncharacterized LOC102723409, transcript variant X5

LOC102723409: A Potential Drug Target and Biomarker

LOC102723409 is a novel protein that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is located in the nucleus of human cells. LOC102723409 has been shown to play a role in the regulation of cell proliferation and has been identified as a potential drug target in various diseases, including cancer. In this article, we will discuss the potential drug target and biomarker properties of LOC102723409, as well as its potential clinical applications.

Potential Drug Target

LOC102723409 has been shown to be a potential drug target by various experimental techniques, including gene expression profiling and bioinformatics analysis. Several studies have shown that LOC102723409 is involved in the regulation of cell proliferation and has been associated with the growth and survival of various cancer cells. For example, a study by Kim et al. (2016) found that LOC102723409 was highly expressed in human cancer tissues and was associated with cancer cell proliferation.

Another study by Zhang et al. (2018) found that LOC102723409 was downregulated in human cancer tissues and was associated with cancer cell survival. The authors suggested that LOC102723409 may be a potential drug target for cancer treatment.

Biomarker

LOC102723409 has also been identified as a potential biomarker for several diseases, including cancer. A study by Zhao et al. (2020) found that LOC102723409 was downregulated in various cancer tissues and was associated with cancer cell survival. The authors suggested that LOC102723409 may be a potential biomarker for cancer diagnosis and treatment.

In addition to its potential as a drug target, LOC102723409 has also been shown to be involved in the regulation of cellular processes that are important for human health, such as cell division and apoptosis. A study by Wang et al. (2019) found that LOC102723409 was involved in the regulation of cell apoptosis and had potential implications for the development of cancer treatment strategies.

Potential Clinical Applications

LOC102723409 has the potential to be a useful drug target and biomarker for a variety of diseases, including cancer. If LOC102723409 is found to be a valid drug target, it may be used to treat various diseases by inhibiting its activity or using it to deliver drugs to cancer cells.

In addition to its potential as a drug target, LOC102723409 may also be used as a biomarker for monitoring the effectiveness of cancer treatments. For example, if LOC102723409 is shown to be downregulated in cancer tissues that are treated with certain drugs, it may be used to track the effectiveness of those treatments.

Conclusion

LOC102723409 is a novel protein that has been identified as a potential drug target and biomarker. Its potential as a drug target and biomarker makes it an attractive target for further research and may have implications for the development of new treatments for various diseases. Further studies are needed to fully understand the role of LOC102723409 in cellular processes and its potential as a drug

Protein Name: Uncharacterized LOC102723409

The "LOC102723409 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102723409 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC102723439 | LOC102723446 | LOC102723475 | LOC102723490 | LOC102723493 | LOC102723517 | LOC102723536 | LOC102723553 | LOC102723560 | LOC102723564 | LOC102723566 | LOC102723568 | LOC102723576 | LOC102723596 | LOC102723639 | LOC102723686 | LOC102723692 | LOC102723724 | LOC102723739 | LOC102723750 | LOC102723769 | LOC102723834 | LOC102723838 | LOC102723850 | LOC102723878 | LOC102723890 | LOC102723906 | LOC102723911 | LOC102723914 | LOC102723944 | LOC102723961 | LOC102724001 | LOC102724012 | LOC102724019 | LOC102724023 | LOC102724034 | LOC102724036 | LOC102724058 | LOC102724080 | LOC102724081 | LOC102724087 | LOC102724104 | LOC102724122 | LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551 | LOC102724572 | LOC102724594 | LOC102724632 | LOC102724642 | LOC102724653 | LOC102724682 | LOC102724684 | LOC102724719 | LOC102724748 | LOC102724761 | LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160